These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 28924920)
21. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models. Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839 [TBL] [Abstract][Full Text] [Related]
22. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker. Visanji NP; Marras C; Hazrati LN; Liu LW; Lang AE Mov Disord; 2014 Apr; 29(4):444-50. PubMed ID: 24375496 [TBL] [Abstract][Full Text] [Related]
23. Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease. Yang J; Luo S; Zhang J; Yu T; Fu Z; Zheng Y; Xu X; Liu C; Fan M; Zhang Z Neurobiol Dis; 2021 Jan; 148():105218. PubMed ID: 33296726 [TBL] [Abstract][Full Text] [Related]
24. Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge. Miraglia F; Betti L; Palego L; Giannaccini G Cent Nerv Syst Agents Med Chem; 2015; 15(2):109-16. PubMed ID: 25896035 [TBL] [Abstract][Full Text] [Related]
26. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Kelly LP; Carvey PM; Keshavarzian A; Shannon KM; Shaikh M; Bakay RA; Kordower JH Mov Disord; 2014 Jul; 29(8):999-1009. PubMed ID: 24898698 [TBL] [Abstract][Full Text] [Related]
27. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Braak H; de Vos RA; Bohl J; Del Tredici K Neurosci Lett; 2006 Mar; 396(1):67-72. PubMed ID: 16330147 [TBL] [Abstract][Full Text] [Related]
28. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease? Volpicelli-Daley LA; Kirik D; Stoyka LE; Standaert DG; Harms AS J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):131-155. PubMed ID: 27018978 [TBL] [Abstract][Full Text] [Related]
29. Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson's disease. Fares MB; Maco B; Oueslati A; Rockenstein E; Ninkina N; Buchman VL; Masliah E; Lashuel HA Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E912-21. PubMed ID: 26839406 [TBL] [Abstract][Full Text] [Related]
30. A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP. Hansen C; Björklund T; Petit GH; Lundblad M; Murmu RP; Brundin P; Li JY Neurobiol Dis; 2013 Aug; 56():145-55. PubMed ID: 23643841 [TBL] [Abstract][Full Text] [Related]
31. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy. Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358 [TBL] [Abstract][Full Text] [Related]
33. Cross-linking for the analysis of α-synuclein in the enteric nervous system. Corbillé AG; Neunlist M; Derkinderen P J Neurochem; 2016 Dec; 139(5):839-847. PubMed ID: 27637918 [TBL] [Abstract][Full Text] [Related]
34. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder? Olanow CW; Brundin P Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095 [TBL] [Abstract][Full Text] [Related]
36. Neuronal ApoE Regulates the Cell-to-Cell Transmission of α-Synuclein. Kang SJ; Kim SJ; Noh HR; Kim BJ; Kim JB; Jin U; Park SA; Park SM Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955451 [TBL] [Abstract][Full Text] [Related]
37. Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease. Xu S; Chan P Biomolecules; 2015 Jun; 5(2):1122-42. PubMed ID: 26057626 [TBL] [Abstract][Full Text] [Related]
38. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice. Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282 [TBL] [Abstract][Full Text] [Related]
39. Limited spread of pathology within the brainstem of α-synuclein BAC transgenic mice inoculated with preformed fibrils into the gastrointestinal tract. Uemura N; Yagi H; Uemura MT; Yamakado H; Takahashi R Neurosci Lett; 2020 Jan; 716():134651. PubMed ID: 31783082 [TBL] [Abstract][Full Text] [Related]
40. Expression pattern and localization of alpha-synuclein in the human enteric nervous system. Böttner M; Zorenkov D; Hellwig I; Barrenschee M; Harde J; Fricke T; Deuschl G; Egberts JH; Becker T; Fritscher-Ravens A; Arlt A; Wedel T Neurobiol Dis; 2012 Dec; 48(3):474-80. PubMed ID: 22850485 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]